PanMETAI combines AI and NMR metabolomics to detect early-stage pancreatic cancer from a blood sample, achieving 93 percent ...
The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).
We thank Faizan Khan and Nick van Es, and Zhang Cheng and Yiqi Jin for their Correspondence regarding our post-hoc analysis of the API-CAT trial1,2 in which we identified four non-cancer related, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results